Keywords: دی متیل فومارات; Multiple sclerosis; Dimethyl fumarate; Adherence; Tolerability; Management; Monitoring; Lymphopenia;
مقالات ISI دی متیل فومارات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دی متیل فومارات; Multiple sclerosis; Dimethyl fumarate; FNG; Lymphopenia; Risk mitigation; Treatment switch;
Keywords: دی متیل فومارات; Dimethyl fumarate; Diabetes mellitus; Multiple sclerosis; Ketonuria; Adverse reaction;
Keywords: دی متیل فومارات; Nitroalkene; Nitro-fatty acid; Electrophiles; Clinical trial; Preclinical development; Bardoxolone-me; Dimethyl fumarate; Nrf2; Nf-kB; Fibrosis; Inflammation; NO2-OA; nitro-oleic acid; NO2-FA; nitro-fatty acid; CXA-10; 10-nitro-oleic acid (10-nitro-octade
Keywords: دی متیل فومارات; Dimethyl fumarate; Memory disorder; Streptozotocin; Neurodegeneration; Microglia; Alzheimer's disease; Age;
Keywords: دی متیل فومارات; γTuRC; γ-tubulin ring complex; γTuSC; γ-tubulin small complex; CDA; citral dimethyl acetal; DMF; dimethyl fumarate; DAPI; 4â²,6â²-diamidino-2-phenyindole, dihydrochloride; sgRNA; single guide RNA; rest; sgRNA-resistant; shRNA; short hairpin RNA; shr
Keywords: دی متیل فومارات; AHR; aryl hydrocarbon receptor; BBB; blood-brain barrier; CNS; central nervous system; CIS; clinically isolated syndrome; EDSS; expanded disability status scale; EAE; experimental autoimmune encephalomyelitis; DC; dendritic cell; DMF; dimethyl fumarate; D
Keywords: دی متیل فومارات; Multiple sclerosis; Alemtuzumab; Dimethyl fumarate; Fingolimod; Natalizumab; Teriflunomide; Adverse effects; Depression; Anxiety; Systematic review;
Keywords: دی متیل فومارات; Dimethyl fumarate; Inflammation; CETP; Hypercholesterolemia; Atherosclerosis; Oxidative stress;
Keywords: دی متیل فومارات; Multiple sclerosis; Dimethyl fumarate; Teriflunomide; Alemtuzumab;
Keywords: دی متیل فومارات; Dimethyl fumarate; Disease modifying therapies; Multiple sclerosis; Immunology;
Keywords: دی متیل فومارات; Dimethyl fumarate (PubChem CID: 637568); teriflunomide (PubChem CID: 54684141); fingolimod (PubChem CID: 107970); Glatiramer acetate (PubChem CID: 3081884); Multiple sclerosis; Dimethyl fumarate; Teriflunomide; Fingolimod; Immunogenetics;
Keywords: دی متیل فومارات; Dimethyl fumarate; Chronic pancreatitis; Rats; Mechanism
Keywords: دی متیل فومارات; Multiple sclerosis; Oxidative stress; Dimethyl fumarate
Keywords: دی متیل فومارات; MS; multiple sclerosis; DMT; disease modifying therapy; RRMS; relapsing-remitting MS; NEDA; no evidence of disease activity; N/E; new or enlarging; GdE; gadolinium enhancing; KP; knowledge program; EQ-5D; European Quality of Life 5-Dimensions; PS; Perform
Keywords: دی متیل فومارات; Dimethyl fumarate; Bovine serum albumin; Dynamic quenching; Multispectroscopic techniques
Keywords: دی متیل فومارات; Dimethyl fumarate; Fingolimod; Comparative efficacy; Discontinuation; Multiple sclerosis
Keywords: دی متیل فومارات; DMF; dimethyl fumarate; OLZ; olsalazine; PCL; polycaprolactone; mPEG; methoxypolyethylene glycols; EDC; 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; DMAP; 4-dimethylaminopyridine; sPCEG; star-PCL-mPEG; sPCEG-azo; star-PCL-azo-mPEG; TEM; tr
Keywords: دی متیل فومارات; APCs; antigen-presenting cells; ARE; antioxidant response element; DMF; dimethyl fumarate; FAEs; fumaric acid esters; GSH; glutathione; HO; heme oxygenase; IFN; interferon; IL; interleukin; iNOS; inducible nitric oxide synthase; Keap1; Kelch ECH associati
Keywords: دی متیل فومارات; Dimethyl fumarate; Memory disorder; Spatial; Streptozotocin; Neurodegeneration; Alzheimer's disease; Hippocampus;
Keywords: دی متیل فومارات; multiple sclerosis; relapses; disease-modifying drugs; central nervous system; disability; magnetic resonance imaging; fingolimod; teriflunomide; dimethyl fumarate
Keywords: دی متیل فومارات; Spherical agglomeration; Dimethyl fumarate; Baffle; Scale up; Dissolution profile; Mechanical property
Keywords: دی متیل فومارات; costs; dimethyl fumarate; hospitalization; methylprednisolone; multiple sclerosis; relapse;
Keywords: دی متیل فومارات; DMF; dimethyl fumarate; MAF-G; musculo-aponeurotic fibrosarcoma-G; Nrf2; nuclear factor erythroid-2 related factor 2; p-Nrf2; phosphorylated nuclear factor erythroid-2 related factor 2; TBCA; (E)-3-(2,3,4,5 tetrabromophenyl)acrylic acid; CK2; casein kinas
Keywords: دی متیل فومارات; AJ; adherens junction; BBB; blood-brain barrier; DMF; dimethyl fumarate; FAE; fumaric acid esters; Gclc; glutamate-cysteine ligase catalytic subunit; Gclm; glutamate-cysteine ligase modifier subunit; HO-1; heme oxygenase-1; Keap-1; kelch-like erythroid
Keywords: دی متیل فومارات; RRMS; Dimethyl fumarate; DMF; Immunomodulation; Neuroprotection;
Keywords: دی متیل فومارات; Multiple sclerosis; Tolerability; Dimethyl fumarate; Adverse events; Gastrointestinal adverse events; Flushing;
Keywords: دی متیل فومارات; Multiple sclerosis; EAE; Immunomodulation; Neuroprotection; Interferon-beta; Dimethyl fumarate; Combination therapy
Keywords: دی متیل فومارات; BBB; blood-brain barrier; CNS; central nervous system; DMF; dimethyl fumarate; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; FDA; Food and Drug Administration; GA; glatiramer acetate; JCV; John Cunningham virus; MRI; magnetic res
Keywords: دی متیل فومارات; dimethyl fumarate; flushing; multiple sclerosis; prostaglandin D2;
Keywords: دی متیل فومارات; multiple sclerosis; oral therapy; dimethyl fumarate; Expanded Disability Status Scale
Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
Keywords: دی متیل فومارات; Relapsing-remitting multiple sclerosis; Dimethyl fumarate; Safety; Efficacy; Pediatric; Pharmacokinetics;
Neuroprotective effect of Nrf2 activator dimethyl fumarate, on the hippocampal neurons in chemical kindling model in rat
Keywords: دی متیل فومارات; CNS; central nervous system; DMF; dimethyl fumarate; PTZ; pentylenetetrazole; VPA; sodium valproate; Nrf2; nuclear factor erythroid-2 related factor 2; GPx; glutathione peroxidase; SOD; superoxide dismutase; GSH; reduced glutathione; HO-1; heme oxygenase
Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro
Keywords: دی متیل فومارات; Dimethyl fumarate; Neurotoxicity; Oxaliplatin; Chemotherapy agents; Nuclear factor-erythroid-2-related factor 2 (Nrf2);
Schwann Cell Plasticity is Regulated by a Weakened Intrinsic Antioxidant Defense System in Acute Peripheral Nerve Injury
Keywords: دی متیل فومارات; Cat; catalase; DMF; dimethyl fumarate; Gclc, Gclm; glutamate-cysteine ligase catalytic subunit and modulatory subunit; Gss; glutathione synthetase; IHC; immunohistochemistry; Keap1; Kelch-like ECH-associated protein-1; MBP; myelin basic protein; Meth; Met
Fatty Acids Prevent Hypoxia-Inducible Factor-1α Signaling Through Decreased Succinate in Diabetes
Keywords: دی متیل فومارات; cardiovascular disease; diabetes; fatty acids; metabolism; HIF-1α; hypoxia; ANOVA; analysis of variance; BSA; bovine serum albumin; DMF; dimethyl fumarate; DMOG; dimethyloxalylglycine; FA; fatty acid; FIH; factor inhibiting hypoxia-inducible factor; HIF;
Dimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: Implications for the treatment of multiple sclerosis
Keywords: دی متیل فومارات; Multiple sclerosis; Dimethyl fumarate; Monomethyl fumarate; Hydroxycarboxylic acid receptor 2;
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis
Keywords: دی متیل فومارات; Akt; protein kinase B; CTGF; connective tissue growth factor; DMF; dimethyl fumarate; EDN1; endothelin 1; GSK-3; glycogen kinase 3; HC; healthy control; MMP; matrix metalloproteinase; NRF2; nuclear factor (erythroid-derived 2)-like 2; PAAm; polyacrylamide
Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis
Keywords: دی متیل فومارات; ROS; reactive oxygen species; NQO-1; NADPH:quinone oxidoreductase 1; HO-1; heme oxygenase-1; ARE; antioxidant response element; Nrf2; nuclear factor erythroid 2-related factor 2; Keap1; Kelch-like ECH-associated protein 1; DMF; dimethyl fumarate; CDDO-Me;
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
Keywords: دی متیل فومارات; AE; adverse event; ARR; annualized relapse rate; DMF; dimethyl fumarate; DMT; disease-modifying therapy; HR; hazard ratio; IPTW; inverse probability of treatment weight; JCV; John Cunningham virus; MS; multiple sclerosis; PML; progressive multifocal leuko
NRF2 mitigates acute alcohol-induced hepatic and pancreatic injury in mice
Keywords: دی متیل فومارات; NRF2; Alcohol; Hepatic injury; Pancreatic injury; Alcoholism; ADH1; alcohol dehydrogenase 1; ALD; alcoholic liver disease; ALDH; aldehyde dehydrogenase; AMS; amylase; ALT; alanine transaminase; ARE; antioxidant response element; AST; aspartate aminotransf
Review articleClassifying PML risk with disease modifying therapies
Keywords: دی متیل فومارات; Disease modifying therapy; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Natalizumab; Fingolimod; Dimethyl fumarate; Rituximab;
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158Â N murine oligodendrocytes
Keywords: دی متیل فومارات; CSF; cerebrospinal fluid; DMF; dimethyl fumarate; 7KC; 7-ketocholesterol; MF; multiple sclerosis; ROS; reactive oxygen species; Dimethyl fumarate; 7-Ketocholesterol; 158Â N cells; Apoptosis; Autophagy; Oxiapoptophagy; Oxidative stress;
Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases
Keywords: دی متیل فومارات; α-SYN; alpha synuclein; β-TrCP; β-transducin repeat containing E3 ubiquitin protein ligase; Aβ; amyloid beta; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; AMPK; AMP-activated protein kinase; ARE; antioxidant response element; ASK1; apo
Research paperNanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior
Keywords: دی متیل فومارات; Solid lipid nanoparticles; Dimethyl fumarate; Brain delivery; Multiple sclerosis; In vivo biodistribution; Fluorescent luminescence imaging;
Review articlePharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research
Keywords: دی متیل فومارات; ADRs; adverse drug reactions; APCs; antigen-presenting cells; ARR; annualized relapse rate; CDMS; clinically definite MS; CIS; clinically-isolated syndrome; CTSS; Cathepsin S gene; DMF; dimethyl fumarate; DMT; disease-modifying therapies; EAE; experimenta
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418
Keywords: دی متیل فومارات; AA; arachidonic acid; methyl-BQ; 2,5-dimethyl-1,4-benzoquinone; CDDO; CDDO-methylester; methoxy-BQ; 2,3-dimethoxy-5-methyl-p-benzoquinone; methoxy-NS; 3-methoxy-β-nitrostyrene; DMF; dimethyl fumarate; GSH; glutathione; OH-BQ; 2,5-dihydroxy-1,4-benzoquino
Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple Sclerosisâ
Keywords: دی متیل فومارات; cost-effectiveness; dimethyl fumarate; economic evaluation; glatiramer acetate; interferon-β; teriflunomide;
Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study
Keywords: دی متیل فومارات; AEs; adverse events; ALT; alanine aminotransferase; BL; baseline; CI; confidence interval; DMF; dimethyl fumarate; DMTs; disease-modifying therapies; EDSS; Expanded Disability Status Scale; ES; effect size; MedDRA; Medical Dictionary for Regulatory Activi
Nuclear protein HMGN2 attenuates pyocyanin-induced oxidative stress via Nrf2 signaling and inhibits Pseudomonas aeruginosa internalization in A549 cells
Keywords: دی متیل فومارات; HMGN2; high mobility group nucleosomal binding protein 2; PA; Pseudomonas aeruginosa; PCN; pyocyanin; Nrf2; nuclear factor (erythroid-derived 2)-like 2; ROS; reactive oxygen species; DCFH-DA; 2â², 7â²-dichlorodihydrofluorescein diacetate; DHE; dihydroet